ウィルソン病治療薬の世界市場レポート 2025年

ウィルソン病治療薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.5％で8億5,000万米ドルに成長します。この成長予測は、革新的な医薬品研究や遺伝子治療への投資の増加、個別化医療の急増、患者教育イニシアチブの拡大、ヘルスケア支出の増加、規制当局の承認拡大などが背景にあります。予測期間中に予想される主な動向には、遺伝子治療の発展、疾患開発を追跡するためのバイオマーカーの応用拡大、デジタルヘルスケアソリューションの統合、希少疾病用医薬品の認定による幅広い認知、投資の増加、併用治療戦略の出現などがあります。

遺伝性疾患の罹患率の上昇は、ウィルソン病治療薬市場の成長を促進すると予測されています。遺伝性疾患は、突然変異、欠失、染色体変化など、個人のDNAの異常によって生じる。遺伝性疾患の増加は、主に親の年齢が高くなり、遺伝可能な変異が子孫に受け継がれる可能性が高くなることに起因しています。ウィルソン病治療薬は、ATP7B遺伝子の変異によって引き起こされる有害な銅の蓄積を減少させることによって、この遺伝的状態を治療するために使用されます。これらの薬は、銅の排泄を促進したり、吸収を阻害したりすることで、肝臓や脳のような重要な臓器を保護します。たとえば、英国を拠点とする国立慈善団体「嚢胞性線維症トラスト」によると、2023年9月、英国で嚢胞性線維症に登録された患者数は、2021年の1万908人から2022年には1万1,148人に増加しました。その結果、遺伝性疾患の有病率の増加がウィルソン病治療薬市場の拡大を支えています。

ウィルソン病治療薬市場の主要企業は、塩酸トリエンチン（TETA-4HCl）などの先進的な製剤を開発し、治療成績の向上と希少疾患の管理における患者の利便性の向上に努めています。トリエンチン・テトラヒドロクロライド（TETA-4HCl）は、安定したウィルソン病の成人患者の銅バランスを維持するために調整された、先進的な経口銅キレート療法です。例えば、2023年4月、フランスを拠点とする希少疾病用医薬品の開発と商業化を専門とするオルファランSAは、キュビオリアを発表しました。FDA（米国食品医薬品局）により承認され、希少疾病用医薬品の独占的使用が認められたCuvriorは、ペニシラミンの減量と耐性が既にある安定型ウィルソン病の成人患者向けに設計された新しいトリエンチン四塩酸塩（TETA-4HCl）製剤です。この製剤は、室温で安定した経口治療薬であり、従来の治療薬と比較して、投与の柔軟性と利便性が向上しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のウィルソン病治療薬：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のウィルソン病治療薬市場：成長率分析
• 世界のウィルソン病治療薬市場の実績：規模と成長, 2019-2024
• 世界のウィルソン病治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界のウィルソン病治療薬：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のウィルソン病治療薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キレート剤
• 亜鉛療法
• 肝臓移植
• 対症療法
• 世界のウィルソン病治療薬市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 静脈内
• 皮下
• 世界のウィルソン病治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他の流通チャネル
• 世界のウィルソン病治療薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界のウィルソン病治療薬市場、キレート剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ペニシラミン
• トリエンティーヌ
• テトラチオモリブデン酸塩
• 実験的キレート剤
• 世界のウィルソン病治療薬市場、亜鉛療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酢酸亜鉛
• グルコン酸亜鉛
• 硫酸亜鉛
• 世界のウィルソン病治療薬市場、肝臓移植の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 同所性肝移植
• 生体肝移植
• 脳死ドナー肝移植
• 世界のウィルソン病治療薬市場、対症療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗精神病薬
• 抗てんかん薬
• 抗うつ薬
• 筋弛緩剤
• 抗コリン薬

第7章 地域別・国別分析

• 世界のウィルソン病治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のウィルソン病治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ウィルソン病治療薬市場：競合情勢
• ウィルソン病治療薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bausch Health Companies Inc.
• Intas Pharmaceuticals Ltd.
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories
• Lupin Pharmaceuticals
• Ultragenyx Pharmaceutical Inc.
• Taj Pharmaceutical Limited
• Biophore Pharma Inc.
• Orphalan SA
• Nobelpharma Co. Ltd
• Eton Pharmaceuticals
• LogicBio Therapeutics
• DepYmed
• Vivet Therapeutics
• Telomir Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ウィルソン病治療薬市場2029年：新たな機会を提供する国
• ウィルソン病治療薬市場2029年：新たな機会を提供するセグメント
• ウィルソン病治療薬市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Wilson's disease drugs are treatments used to address a rare inherited disorder that causes excessive copper accumulation, primarily in the liver and brain. These medications function by either promoting the elimination of copper from the body or preventing its absorption. Their main goal is to avoid or reverse damage to organs, especially the liver and nervous system.

The key categories of Wilson's disease drugs include chelating agents, zinc-based therapies, liver transplantation, and supportive symptom management. Chelating agents help manage Wilson's disease by binding to surplus copper, allowing it to be excreted through urine, thereby quickly decreasing copper toxicity. These drugs are administered via oral, intravenous, and subcutaneous routes and are distributed through hospital pharmacies, retail outlets, online platforms, and other channels. They are utilized by various end-users, such as hospitals, home care providers, specialty clinics, and more.

The wilson's disease drugs market research report is one of a series of new reports from The Business Research Company that provides wilson's disease drugs market statistics, including the wilson's disease drugs industry global market size, regional shares, competitors with the wilson's disease drugs market share, detailed wilson's disease drugs market segments, market trends, opportunities, and any further data you may need to thrive in the wilson's disease drugs industry. This Wilson's disease drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The wilson's disease drugs market size has grown strongly in recent years. It will grow from $0.62 billion in 2024 to $0.66 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The historical growth can be linked to increased awareness about Wilson's disease and its symptoms, expanded clinical research activities, broader access to standardized treatments, improvements in healthcare infrastructure, and a higher number of diagnosed patients.

The wilson's disease drugs market size is expected to see strong growth in the next few years. It will grow to $0.85 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. This projected growth is driven by higher investments in innovative drug research and gene therapy, a surge in personalized medicine practices, expansion of patient education initiatives, increased healthcare expenditure, and more regulatory approvals. Key trends expected during the forecast period include advancements in gene therapy, increased application of biomarkers to track disease development, integration of digital healthcare solutions, broader recognition through orphan drug status, rising investments, and the emergence of combination treatment strategies.

The rising incidence of genetic disorders is anticipated to drive the growth of the Wilson's disease drugs market. Genetic disorders result from abnormalities in an individual's DNA, including mutations, deletions, or chromosomal changes. The increase in genetic disorders is primarily attributed to higher parental age, which elevates the likelihood of inheritable mutations being passed to offspring. Wilson's disease drugs are used to treat this genetic condition by reducing harmful copper accumulation caused by ATP7B gene mutations. These drugs work by promoting copper excretion or inhibiting its absorption, thereby protecting vital organs such as the liver and brain. For example, according to the Cystic Fibrosis Trust, a UK-based national charity, in September 2023, the number of patients in the UK registered with cystic fibrosis rose to 11,148 in 2022, up from 10,908 in 2021. Consequently, the increasing prevalence of genetic disorders is supporting the expansion of the Wilson's disease drugs market.

Leading companies in the Wilson's disease drug market are developing advanced drug formulations, such as trientine tetrahydrochloride (TETA-4HCl), to improve treatment outcomes and enhance patient convenience in managing rare diseases. Trientine tetrahydrochloride (TETA-4HCl) is an advanced oral copper-chelating therapy tailored to maintain copper balance in adult patients with stable Wilson's disease. For instance, in April 2023, Orphalan SA, a France-based company specializing in orphan drug development and commercialization, introduced Cuvrior. Approved by the Food and Drug Administration (FDA) and granted Orphan Drug Exclusivity, Cuvrior is a new trientine tetrahydrochloride (TETA-4HCl) formulation designed for adults with stable Wilson's disease who are already decoppered and tolerant to penicillamine. It offers a room temperature-stable oral therapy that enhances dosing flexibility and convenience compared to earlier treatments.

In January 2025, Eton Pharmaceuticals, a US-based pharmaceutical company, acquired Galzin from Teva Pharmaceuticals USA for an undisclosed amount. This acquisition reflects Eton Pharmaceuticals' dedication to rare disease treatments by adding an FDA-approved therapy for the ultra-rare metabolic condition Wilson's disease to its portfolio. Teva Pharmaceuticals USA, Inc. is a US-based pharmaceutical manufacturer of Wilson's disease drugs.

Major players in the wilson's disease drugs market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Lupin Pharmaceuticals, Ultragenyx Pharmaceutical Inc., Taj Pharmaceutical Limited, Biophore Pharma Inc., Orphalan SA, Nobelpharma Co. Ltd, Eton Pharmaceuticals, LogicBio Therapeutics, DepYmed, Vivet Therapeutics, Telomir Pharmaceuticals Inc., and Innorna.

North America was the largest region in the wilson's disease drugs market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Wilson's Disease Drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The wilson's disease drugs market consists of sales of zinc salts, penicillamine, and trientine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wilson's Disease Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wilson's disease drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wilson's disease drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The wilson's disease drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Chelating Agents; Zinc Therapy; Liver Transplant; Symptomatic Treatments
• 2) By Route Of Administration: Oral; Intravenous; Subcutaneous
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacies; Other Distribution Channels
• 4) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Chelating Agents: Penicillamine; Trientine; Tetrathiomolybdate; Experimental Chelators
• 2) By Zinc Therapy: Zinc Acetate; Zinc Gluconate; Zinc Sulfate
• 3) By Liver Transplant: Orthotopic Liver Transplantation; Living Donor Liver Transplantation; Deceased Donor Liver Transplantation
• 4) By Symptomatic Treatments: Antipsychotic Medications; Antiepileptic Drugs; Antidepressants; Muscle Relaxants; Anticholinergics
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Sanofi S.A.; AstraZeneca plc; Teva Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Wilson's Disease Drugs Market Characteristics

3. Wilson's Disease Drugs Market Trends And Strategies

4. Wilson's Disease Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Wilson's Disease Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Wilson's Disease Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Wilson's Disease Drugs Market Growth Rate Analysis
• 5.4. Global Wilson's Disease Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Wilson's Disease Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Wilson's Disease Drugs Total Addressable Market (TAM)

6. Wilson's Disease Drugs Market Segmentation

• 6.1. Global Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chelating Agents
• Zinc Therapy
• Liver Transplant
• Symptomatic Treatments
• 6.2. Global Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravenous
• Subcutaneous
• 6.3. Global Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Wilson's Disease Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.5. Global Wilson's Disease Drugs Market, Sub-Segmentation Of Chelating Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillamine
• Trientine
• Tetrathiomolybdate
• Experimental Chelators
• 6.6. Global Wilson's Disease Drugs Market, Sub-Segmentation Of Zinc Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Zinc Acetate
• Zinc Gluconate
• Zinc Sulfate
• 6.7. Global Wilson's Disease Drugs Market, Sub-Segmentation Of Liver Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Orthotopic Liver Transplantation
• Living Donor Liver Transplantation
• Deceased Donor Liver Transplantation
• 6.8. Global Wilson's Disease Drugs Market, Sub-Segmentation Of Symptomatic Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antipsychotic Medications
• Antiepileptic Drugs
• Antidepressants
• Muscle Relaxants
• Anticholinergics

7. Wilson's Disease Drugs Market Regional And Country Analysis

• 7.1. Global Wilson's Disease Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Wilson's Disease Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Wilson's Disease Drugs Market

• 8.1. Asia-Pacific Wilson's Disease Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Wilson's Disease Drugs Market

• 9.1. China Wilson's Disease Drugs Market Overview
• 9.2. China Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Wilson's Disease Drugs Market

• 10.1. India Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Wilson's Disease Drugs Market

• 11.1. Japan Wilson's Disease Drugs Market Overview
• 11.2. Japan Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Wilson's Disease Drugs Market

• 12.1. Australia Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Wilson's Disease Drugs Market

• 13.1. Indonesia Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Wilson's Disease Drugs Market

• 14.1. South Korea Wilson's Disease Drugs Market Overview
• 14.2. South Korea Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Wilson's Disease Drugs Market

• 15.1. Western Europe Wilson's Disease Drugs Market Overview
• 15.2. Western Europe Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Wilson's Disease Drugs Market

• 16.1. UK Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Wilson's Disease Drugs Market

• 17.1. Germany Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Wilson's Disease Drugs Market

• 18.1. France Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Wilson's Disease Drugs Market

• 19.1. Italy Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Wilson's Disease Drugs Market

• 20.1. Spain Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Wilson's Disease Drugs Market

• 21.1. Eastern Europe Wilson's Disease Drugs Market Overview
• 21.2. Eastern Europe Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Wilson's Disease Drugs Market

• 22.1. Russia Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Wilson's Disease Drugs Market

• 23.1. North America Wilson's Disease Drugs Market Overview
• 23.2. North America Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Wilson's Disease Drugs Market

• 24.1. USA Wilson's Disease Drugs Market Overview
• 24.2. USA Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Wilson's Disease Drugs Market

• 25.1. Canada Wilson's Disease Drugs Market Overview
• 25.2. Canada Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Wilson's Disease Drugs Market

• 26.1. South America Wilson's Disease Drugs Market Overview
• 26.2. South America Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Wilson's Disease Drugs Market

• 27.1. Brazil Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Wilson's Disease Drugs Market

• 28.1. Middle East Wilson's Disease Drugs Market Overview
• 28.2. Middle East Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Wilson's Disease Drugs Market

• 29.1. Africa Wilson's Disease Drugs Market Overview
• 29.2. Africa Wilson's Disease Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Wilson's Disease Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Wilson's Disease Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Wilson's Disease Drugs Market Competitive Landscape And Company Profiles

• 30.1. Wilson's Disease Drugs Market Competitive Landscape
• 30.2. Wilson's Disease Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Wilson's Disease Drugs Market Other Major And Innovative Companies

• 31.1. Bausch Health Companies Inc.
• 31.2. Intas Pharmaceuticals Ltd.
• 31.3. Sun Pharmaceutical Industries Ltd.
• 31.4. Dr. Reddy's Laboratories
• 31.5. Lupin Pharmaceuticals
• 31.6. Ultragenyx Pharmaceutical Inc.
• 31.7. Taj Pharmaceutical Limited
• 31.8. Biophore Pharma Inc.
• 31.9. Orphalan SA
• 31.10. Nobelpharma Co. Ltd
• 31.11. Eton Pharmaceuticals
• 31.12. LogicBio Therapeutics
• 31.13. DepYmed
• 31.14. Vivet Therapeutics
• 31.15. Telomir Pharmaceuticals Inc.

32. Global Wilson's Disease Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wilson's Disease Drugs Market

34. Recent Developments In The Wilson's Disease Drugs Market

35. Wilson's Disease Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Wilson's Disease Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Wilson's Disease Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Wilson's Disease Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer